文献速递耳科与耳神经小儿耳鼻咽喉

Usher 综合征亚型的多中心自然史研究及人工耳蜗远期效果

Multicenter Natural History Study and Long-Term Cochlear Implant Outcomes in Usher Syndrome Subtypes.
PubMed 文献 · Ear Hear · 2026-04-23

这项回顾性多中心队列研究分析 33 例基因确诊 Usher 综合征患者(66 耳)的 655 份听力图,随访平均 7 年 10 个月,评估助听器与人工耳蜗的长期效果。结果显示助听器平均改善 20.1 dB HL,但随自然病程仍会下降;人工耳蜗植入后 1 年平均阈值 37.9 dB HL,15 至 20 年达 27.5 dB HL,所有植入者均获益。

要点

  • 助听器平均改善 20.1 dB HL,但不阻止感音神经性听力损失自然进展。
  • 人工耳蜗植入后 1 年平均阈值 37.9 dB HL,15 至 20 年达 27.5 dB HL。
  • 所有接受人工耳蜗者均获益,与植入年龄或 USH 致病突变无关。

核心结论

  • 助听器可短期改善听力但无法阻止 Usher 综合征感音神经性听力损失的自然进展。
  • 人工耳蜗植入可长期稳定改善重度至极重度感音神经性听力损失或全聋患者的听力。
  • 本研究结果可作为新型基因治疗对比当前临床标准治疗的基准。

研究设计与样本

  • 回顾性多中心队列研究,纳入 33 例基因确诊 Usher 综合征患者共 66 耳。
  • 分析 655 份听力图,随访总体平均 7 年 10 个月(SD 9 年 11 个月)。
  • 人工耳蜗植入后随访平均 8 年 2 个月(SD 6 年 3 个月)。

主要发现

  • 助听器平均改善阈值 20.1 dB HL(SD 10.9),与年龄无关,但 aided hearing 仍随自然病程下降。
  • 人工耳蜗植入后 1 年平均阈值 37.9 dB HL(SD 7.0),2 年 37.3 dB HL(SD 10.3),15 至 20 年 27.5 dB HL(SD 7.1)。
  • 所有接受人工耳蜗植入的患者均获益,与植入年龄或致病 USH 突变无关。

临床怎么用

  • 对 Usher 综合征重度至极重度感音神经性听力损失或全聋患者,人工耳蜗植入可带来长期听力获益。
  • 助听器可改善听力阈值,但需预期其效果随自然病程进展而下降。
  • 植入年龄或 USH 突变类型不应成为排除人工耳蜗植入的依据。

局限性

  • 回顾性研究设计。
  • 样本量较小(33 例患者,66 耳)。
  • 现有研究随访时间普遍较短且多来自单中心,很少区分 USH 亚型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Usher syndrome (USH) is an inherited disorder that causes bilateral sensorineural hearing loss (SNHL), retinitis pigmentosa, and vestibular defects. It represents the most common cause of combined deaf-blindness worldwide. Mutations in the nine known underlying genes are categorized into three types: USH type 1 has the earliest, most severe onset, while the much more common USH type 2 is comparatively mild with delayed onset and moderate symptoms. USH type 3 is very rare and exhibits variable clinical manifestations. The current standard of care for SNHL in USH is comprised of conventional hearing aids and/or cochlear implantation depending on the severity of symptoms. However, existing studies on treatment outcomes generally have rather short follow-up durations from a single institution and rarely distinguish between the individual USH subtypes. DESIGN: This retrospective multicenter cohort study analyzed 655 audiograms of 33 patients (66 ears) with genetically confirmed USH. Patient-specific characteristics and treatments were correlated with pure-tone average thresholds and speech perception performance over a mean (SD) of 7 yrs and 10 mo (9 yrs and 11 mo) overall and 8 yrs and 2 mo (6 yrs and 3 mo) after cochlear implantation. RESULTS: Conventional hearing aids improved thresholds on average (SD) by 20.1 (10.9) dB HL regardless of age, but aided hearing still deteriorated concurrently with the natural progression of SNHL. In patients with severe-to-profound SNHL or complete deafness, cochlear implantation rescued hearing to average thresholds of 37.9 (7.0) dB HL 1 yr post-implantation, 37.3 (10.3) dB HL after 2 years, and 27.5 (7.1) dB HL after 15 to 20 yrs. Every single patient who received an implant benefited from it, irrespective of the age at implantation or the causative USH mutation. CONCLUSIONS: With new gene therapies for USH in development, the findings reported here can serve as a benchmark for the comparison of novel treatments with the current clinical standard of care around the world. Larger-scale studies with more consistent monitoring of hearing and speech perception ability, as well as more extensive genetic testing, could further elucidate the benefits of current treatments for different (sub-)types of USH.

来源:Ear Hear,查看原文。版权归原作者所有。

引用

  1. Krumpoeck PE, Gadenstaetter AJ, Uehara N, et al. Multicenter Natural History Study and Long-Term Cochlear Implant Outcomes in Usher Syndrome Subtypes. Ear Hear. 2026. PMID: 42020935. doi:10.1097/AUD.0000000000001822

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。